Daniel Hassan just submitted his thesis for PhD in Pharmaceutics at the laboratory of Prof. Thirumala Govender at the University of KwaZulu-Natal (South Africa). His PhD project focused on developing different novel nano-medicines to combat antibiotic-resistant caused by Methicillin-resistant Staphylococcus aureus (MRSA). He synthesised novel compounds, formulated and characterized the nanoparticles (nanoplexes, nanovesicles and quatsomes) and investigated theirs in vitro and in vivo antimicrobial activities in BALB/c mice model. Prior to that, He graduated with a Master of Business Administration (MBA) and a Master’s degree in Pharmaceutical Sciences from Cardiff Metropolitan University and the University of Greenwich respectively in the United Kingdom (UK). Daniel cherish working with dedicated professionals having ambitious developmental mindset to achieve definite goals. He is currently serving as one of the British Society for Antimicrobial Society (BSAC) council board member and American Society for Microbiology (ASM) Young Ambassador to South Africa leading to his interest in joining the CRS Young Scientist Committee. Daniel joined CRS in 2017 and is looking forward to working together with others in advancing the society’s development. He is grateful and excited to be part of the CRS Young Scientist Committee to foster, develop and contribute to scientific community profession. In her own time, He enjoys listening to music, traveling, getting socialize with new friends and family; and finally love photographing.
